Friday, October 30, 2020 2:25:05 PM
I have been in this stock when it was $0.06. I believe in the science. I have confidence in the drug and I also see hundreds dying from an illness that can be reduced to a common cold with the use of this drug. My ICU was part of the double blind study in the use of IV aviptadil in critically ill patients. I can’t tell you who was taking the placebo vs the drug, so don’t ask. I do know that humanity must now inconveniently wait and die while for the governing bodies take their precious time. I’ll bet the families of the victims of Covid-19 could care less who is in office if only to have their loved offered a chance or hope of survival.
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
- Micro-Cap Biotech Skyrockets on FDA Pediatric Disease Nod • AllPennyStocks.com • 05/22/2025 04:49:00 PM
